CA2977422A1 - Methods for diagnosis of sepsis - Google Patents
Methods for diagnosis of sepsis Download PDFInfo
- Publication number
- CA2977422A1 CA2977422A1 CA2977422A CA2977422A CA2977422A1 CA 2977422 A1 CA2977422 A1 CA 2977422A1 CA 2977422 A CA2977422 A CA 2977422A CA 2977422 A CA2977422 A CA 2977422A CA 2977422 A1 CA2977422 A1 CA 2977422A1
- Authority
- CA
- Canada
- Prior art keywords
- sepsis
- subject
- biomarkers
- expression
- infection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010040047 Sepsis Diseases 0.000 title claims abstract description 407
- 238000000034 method Methods 0.000 title claims abstract description 145
- 238000003745 diagnosis Methods 0.000 title claims abstract description 95
- 239000000090 biomarker Substances 0.000 claims abstract description 265
- 208000014674 injury Diseases 0.000 claims abstract description 185
- 206010051379 Systemic Inflammatory Response Syndrome Diseases 0.000 claims abstract description 131
- 238000001356 surgical procedure Methods 0.000 claims abstract description 29
- 230000008736 traumatic injury Effects 0.000 claims abstract description 16
- 208000023275 Autoimmune disease Diseases 0.000 claims abstract description 11
- 208000015181 infectious disease Diseases 0.000 claims description 331
- 239000002157 polynucleotide Substances 0.000 claims description 183
- 102000040430 polynucleotide Human genes 0.000 claims description 182
- 108091033319 polynucleotide Proteins 0.000 claims description 182
- 108090000623 proteins and genes Proteins 0.000 claims description 161
- 230000014509 gene expression Effects 0.000 claims description 157
- 239000000523 sample Substances 0.000 claims description 128
- 108091034117 Oligonucleotide Proteins 0.000 claims description 69
- 238000002493 microarray Methods 0.000 claims description 55
- 238000004458 analytical method Methods 0.000 claims description 53
- 239000012472 biological sample Substances 0.000 claims description 52
- 239000008280 blood Substances 0.000 claims description 51
- 210000000440 neutrophil Anatomy 0.000 claims description 51
- 108010062802 CD66 antigens Proteins 0.000 claims description 48
- 102100024533 Carcinoembryonic antigen-related cell adhesion molecule 1 Human genes 0.000 claims description 48
- 102100021703 C3a anaphylatoxin chemotactic receptor Human genes 0.000 claims description 47
- 101000896583 Homo sapiens C3a anaphylatoxin chemotactic receptor Proteins 0.000 claims description 47
- 101000904080 Homo sapiens Guanine nucleotide-binding protein subunit alpha-15 Proteins 0.000 claims description 47
- 101000911541 Homo sapiens Protein FAM214A Proteins 0.000 claims description 47
- 102100023198 Mitochondrial carrier homolog 1 Human genes 0.000 claims description 47
- 102100026957 Protein FAM214A Human genes 0.000 claims description 47
- 102100021398 Transforming growth factor-beta-induced protein ig-h3 Human genes 0.000 claims description 47
- 102100040089 X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 Human genes 0.000 claims description 47
- 210000004369 blood Anatomy 0.000 claims description 47
- 102100023954 Guanine nucleotide-binding protein subunit alpha-15 Human genes 0.000 claims description 46
- 101000903742 Homo sapiens Basic leucine zipper transcriptional factor ATF-like Proteins 0.000 claims description 46
- 101000818425 Homo sapiens Palmitoyltransferase ZDHHC19 Proteins 0.000 claims description 46
- 102100021068 Palmitoyltransferase ZDHHC19 Human genes 0.000 claims description 46
- 101000623667 Homo sapiens Mitochondrial carrier homolog 1 Proteins 0.000 claims description 44
- 101000894525 Homo sapiens Transforming growth factor-beta-induced protein ig-h3 Proteins 0.000 claims description 44
- 101001104110 Homo sapiens X-linked retinitis pigmentosa GTPase regulator-interacting protein 1 Proteins 0.000 claims description 44
- 210000004027 cell Anatomy 0.000 claims description 42
- 102100031618 HLA class II histocompatibility antigen, DP beta 1 chain Human genes 0.000 claims description 40
- 108010045483 HLA-DPB1 antigen Proteins 0.000 claims description 40
- 102000039446 nucleic acids Human genes 0.000 claims description 35
- 108020004707 nucleic acids Proteins 0.000 claims description 35
- 150000007523 nucleic acids Chemical class 0.000 claims description 35
- 102100022970 Basic leucine zipper transcriptional factor ATF-like Human genes 0.000 claims description 34
- 230000002458 infectious effect Effects 0.000 claims description 32
- 238000003752 polymerase chain reaction Methods 0.000 claims description 30
- 101000633302 Homo sapiens Nicotinamide riboside kinase 1 Proteins 0.000 claims description 28
- 102100029562 Nicotinamide riboside kinase 1 Human genes 0.000 claims description 28
- 238000003860 storage Methods 0.000 claims description 23
- 210000001616 monocyte Anatomy 0.000 claims description 17
- 239000003795 chemical substances by application Substances 0.000 claims description 15
- 102000004169 proteins and genes Human genes 0.000 claims description 15
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 14
- 230000003247 decreasing effect Effects 0.000 claims description 14
- 238000005516 engineering process Methods 0.000 claims description 14
- 238000002560 therapeutic procedure Methods 0.000 claims description 14
- 238000010240 RT-PCR analysis Methods 0.000 claims description 13
- 230000003321 amplification Effects 0.000 claims description 13
- 210000000678 band cell Anatomy 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 13
- 238000003196 serial analysis of gene expression Methods 0.000 claims description 13
- 238000000338 in vitro Methods 0.000 claims description 10
- 210000005259 peripheral blood Anatomy 0.000 claims description 10
- 239000011886 peripheral blood Substances 0.000 claims description 10
- 239000003242 anti bacterial agent Substances 0.000 claims description 9
- 229940088710 antibiotic agent Drugs 0.000 claims description 9
- 238000001514 detection method Methods 0.000 claims description 9
- 238000010208 microarray analysis Methods 0.000 claims description 9
- 210000002966 serum Anatomy 0.000 claims description 8
- 238000000636 Northern blotting Methods 0.000 claims description 7
- 210000002381 plasma Anatomy 0.000 claims description 7
- 238000007418 data mining Methods 0.000 claims description 6
- 239000007850 fluorescent dye Substances 0.000 claims description 5
- 238000012544 monitoring process Methods 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 238000004422 calculation algorithm Methods 0.000 claims description 4
- 230000004968 inflammatory condition Effects 0.000 claims description 4
- 101150111527 HLA-DPB1 gene Proteins 0.000 claims 3
- 101100458431 Homo sapiens MTCH1 gene Proteins 0.000 claims 3
- 101150089537 MTCH1 gene Proteins 0.000 claims 3
- 101150093838 RPGRIP1 gene Proteins 0.000 claims 3
- 101150040304 TGFBI gene Proteins 0.000 claims 3
- 101000763481 Homo sapiens Transmembrane protein 245 Proteins 0.000 claims 1
- 102100027012 Transmembrane protein 245 Human genes 0.000 claims 1
- 230000000155 isotopic effect Effects 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 abstract description 48
- 230000004054 inflammatory process Effects 0.000 abstract description 48
- 238000011282 treatment Methods 0.000 abstract description 16
- 208000007536 Thrombosis Diseases 0.000 abstract description 10
- 238000004393 prognosis Methods 0.000 abstract description 9
- 230000008733 trauma Effects 0.000 description 129
- 239000003292 glue Substances 0.000 description 70
- 238000010200 validation analysis Methods 0.000 description 49
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 44
- 230000000694 effects Effects 0.000 description 41
- 208000027418 Wounds and injury Diseases 0.000 description 39
- 230000006378 damage Effects 0.000 description 36
- 101150000874 11 gene Proteins 0.000 description 34
- 108091059597 FAIM3 Proteins 0.000 description 31
- 102100037815 Fas apoptotic inhibitory molecule 3 Human genes 0.000 description 31
- 102100022898 Galactoside-binding soluble lectin 13 Human genes 0.000 description 30
- 101000620927 Homo sapiens Galactoside-binding soluble lectin 13 Proteins 0.000 description 30
- 101000691480 Homo sapiens Placenta-specific gene 8 protein Proteins 0.000 description 30
- 230000001580 bacterial effect Effects 0.000 description 30
- 238000000513 principal component analysis Methods 0.000 description 28
- 238000010198 multi-cohort analysis Methods 0.000 description 27
- 238000012360 testing method Methods 0.000 description 27
- 108020004414 DNA Proteins 0.000 description 25
- 238000009396 hybridization Methods 0.000 description 25
- 238000003491 array Methods 0.000 description 24
- 239000002773 nucleotide Substances 0.000 description 23
- 125000003729 nucleotide group Chemical group 0.000 description 23
- 230000001154 acute effect Effects 0.000 description 20
- -1 CEACAM Proteins 0.000 description 19
- 238000013103 analytical ultracentrifugation Methods 0.000 description 19
- 238000003556 assay Methods 0.000 description 19
- 208000036142 Viral infection Diseases 0.000 description 18
- 230000009385 viral infection Effects 0.000 description 17
- 206010035664 Pneumonia Diseases 0.000 description 16
- 208000035143 Bacterial infection Diseases 0.000 description 15
- 208000022362 bacterial infectious disease Diseases 0.000 description 15
- 239000002299 complementary DNA Substances 0.000 description 15
- 230000003612 virological effect Effects 0.000 description 15
- 239000012634 fragment Substances 0.000 description 14
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- 101710163270 Nuclease Proteins 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 13
- 108010048233 Procalcitonin Proteins 0.000 description 12
- CWCXERYKLSEGEZ-KDKHKZEGSA-N procalcitonin Chemical compound C([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)NCC(O)=O)[C@@H](C)O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCSC)NC(=O)[C@H]1NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@@H](N)CSSC1)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 CWCXERYKLSEGEZ-KDKHKZEGSA-N 0.000 description 12
- 238000011084 recovery Methods 0.000 description 12
- 230000004044 response Effects 0.000 description 12
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 108020004999 messenger RNA Proteins 0.000 description 11
- 206010040070 Septic Shock Diseases 0.000 description 10
- 230000027455 binding Effects 0.000 description 10
- 239000011159 matrix material Substances 0.000 description 10
- 238000010197 meta-analysis Methods 0.000 description 10
- 239000013615 primer Substances 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 108091028043 Nucleic acid sequence Proteins 0.000 description 9
- 208000009470 Ventilator-Associated Pneumonia Diseases 0.000 description 9
- 230000000295 complement effect Effects 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 230000036303 septic shock Effects 0.000 description 9
- 230000009885 systemic effect Effects 0.000 description 9
- 108091023040 Transcription factor Proteins 0.000 description 8
- 102000040945 Transcription factor Human genes 0.000 description 8
- 230000001363 autoimmune Effects 0.000 description 8
- 230000000875 corresponding effect Effects 0.000 description 8
- 239000011521 glass Substances 0.000 description 8
- 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 8
- 238000000585 Mann–Whitney U test Methods 0.000 description 7
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 7
- 238000000540 analysis of variance Methods 0.000 description 7
- 230000008859 change Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- 239000000975 dye Substances 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 238000007477 logistic regression Methods 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 230000009897 systematic effect Effects 0.000 description 7
- 208000028399 Critical Illness Diseases 0.000 description 6
- 206010029803 Nosocomial infection Diseases 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 206010022000 influenza Diseases 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 102100025472 Carcinoembryonic antigen-related cell adhesion molecule 4 Human genes 0.000 description 5
- 101000914325 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 4 Proteins 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 239000013068 control sample Substances 0.000 description 5
- 238000011223 gene expression profiling Methods 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 210000002865 immune cell Anatomy 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 5
- 238000012417 linear regression Methods 0.000 description 5
- 239000003550 marker Substances 0.000 description 5
- 238000010369 molecular cloning Methods 0.000 description 5
- 238000010606 normalization Methods 0.000 description 5
- 239000013610 patient sample Substances 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 230000001105 regulatory effect Effects 0.000 description 5
- 238000011160 research Methods 0.000 description 5
- 238000010839 reverse transcription Methods 0.000 description 5
- 238000012552 review Methods 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 4
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 4
- 102000053602 DNA Human genes 0.000 description 4
- 102100031780 Endonuclease Human genes 0.000 description 4
- 108700039887 Essential Genes Proteins 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 108010006785 Taq Polymerase Proteins 0.000 description 4
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 4
- 230000005784 autoimmunity Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- 238000012937 correction Methods 0.000 description 4
- 238000013461 design Methods 0.000 description 4
- 238000010195 expression analysis Methods 0.000 description 4
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 230000015654 memory Effects 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 230000035939 shock Effects 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 230000002103 transcriptional effect Effects 0.000 description 4
- TYIRBZOAKBEYEJ-UHFFFAOYSA-N 2-(1,3-dimethyl-2,6-dioxopurin-7-yl)ethyl 2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetate Chemical compound C1=CC(C)=CC=C1C(=O)C(N1C)=CC=C1CC(=O)OCCN1C(C(=O)N(C)C(=O)N2C)=C2N=C1 TYIRBZOAKBEYEJ-UHFFFAOYSA-N 0.000 description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 3
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- 108090000695 Cytokines Proteins 0.000 description 3
- 102000004127 Cytokines Human genes 0.000 description 3
- 238000000018 DNA microarray Methods 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 208000006816 Neonatal Sepsis Diseases 0.000 description 3
- 239000004677 Nylon Substances 0.000 description 3
- 108091034057 RNA (poly(A)) Proteins 0.000 description 3
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 3
- 238000011529 RT qPCR Methods 0.000 description 3
- 241000685914 Sepsis sepsi Species 0.000 description 3
- 108020004682 Single-Stranded DNA Proteins 0.000 description 3
- 108700009124 Transcription Initiation Site Proteins 0.000 description 3
- 101150095029 W gene Proteins 0.000 description 3
- 238000004873 anchoring Methods 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 201000005008 bacterial sepsis Diseases 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000012790 confirmation Methods 0.000 description 3
- 239000013256 coordination polymer Substances 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000002405 diagnostic procedure Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 3
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 3
- 230000028993 immune response Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 238000013507 mapping Methods 0.000 description 3
- 239000004005 microsphere Substances 0.000 description 3
- 239000013642 negative control Substances 0.000 description 3
- 229920001778 nylon Polymers 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- 229920003023 plastic Polymers 0.000 description 3
- 239000013641 positive control Substances 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 230000000770 proinflammatory effect Effects 0.000 description 3
- 239000002096 quantum dot Substances 0.000 description 3
- 230000002285 radioactive effect Effects 0.000 description 3
- 238000003753 real-time PCR Methods 0.000 description 3
- 210000003289 regulatory T cell Anatomy 0.000 description 3
- 230000008458 response to injury Effects 0.000 description 3
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000013515 script Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 230000009466 transformation Effects 0.000 description 3
- 239000013598 vector Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical group N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 101710169336 5'-deoxyadenosine deaminase Proteins 0.000 description 2
- 102100036664 Adenosine deaminase Human genes 0.000 description 2
- 102100024321 Alkaline phosphatase, placental type Human genes 0.000 description 2
- 108091093088 Amplicon Proteins 0.000 description 2
- 101100184045 Arabidopsis thaliana MICU gene Proteins 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241001453380 Burkholderia Species 0.000 description 2
- 108090000342 C-Type Lectins Proteins 0.000 description 2
- 102000003930 C-Type Lectins Human genes 0.000 description 2
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 239000003298 DNA probe Substances 0.000 description 2
- 208000001490 Dengue Diseases 0.000 description 2
- 206010012310 Dengue fever Diseases 0.000 description 2
- 101001091269 Escherichia coli Hygromycin-B 4-O-kinase Proteins 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 description 2
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 description 2
- 108090001005 Interleukin-6 Proteins 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 102000012064 NLR Proteins Human genes 0.000 description 2
- 108091005686 NOD-like receptors Proteins 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 108091000080 Phosphotransferase Proteins 0.000 description 2
- 102000000850 Proto-Oncogene Proteins c-rel Human genes 0.000 description 2
- 108010001859 Proto-Oncogene Proteins c-rel Proteins 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 238000012341 Quantitative reverse-transcriptase PCR Methods 0.000 description 2
- 108020004518 RNA Probes Proteins 0.000 description 2
- 239000003391 RNA probe Substances 0.000 description 2
- 239000013614 RNA sample Substances 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 101001091268 Streptomyces hygroscopicus Hygromycin-B 7''-O-kinase Proteins 0.000 description 2
- 108010022394 Threonine synthase Proteins 0.000 description 2
- 102000002689 Toll-like receptor Human genes 0.000 description 2
- 108020000411 Toll-like receptor Proteins 0.000 description 2
- 206010071362 Viral sepsis Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 108010027570 Xanthine phosphoribosyltransferase Proteins 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 108091092328 cellular RNA Proteins 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 238000003759 clinical diagnosis Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 108010082025 cyan fluorescent protein Proteins 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 210000004443 dendritic cell Anatomy 0.000 description 2
- 208000025729 dengue disease Diseases 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 230000009274 differential gene expression Effects 0.000 description 2
- 102000004419 dihydrofolate reductase Human genes 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000000556 factor analysis Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000015788 innate immune response Effects 0.000 description 2
- DLBFLQKQABVKGT-UHFFFAOYSA-L lucifer yellow dye Chemical compound [Li+].[Li+].[O-]S(=O)(=O)C1=CC(C(N(C(=O)NN)C2=O)=O)=C3C2=CC(S([O-])(=O)=O)=CC3=C1N DLBFLQKQABVKGT-UHFFFAOYSA-L 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 239000011859 microparticle Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 239000002159 nanocrystal Substances 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- 238000007899 nucleic acid hybridization Methods 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 238000007427 paired t-test Methods 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 230000007310 pathophysiology Effects 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- 150000008300 phosphoramidites Chemical class 0.000 description 2
- 102000020233 phosphotransferase Human genes 0.000 description 2
- 108010031345 placental alkaline phosphatase Proteins 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 238000013180 random effects model Methods 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 230000011664 signaling Effects 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 238000013517 stratification Methods 0.000 description 2
- 230000000153 supplemental effect Effects 0.000 description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
- 230000000472 traumatic effect Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 239000011534 wash buffer Substances 0.000 description 2
- 108091005957 yellow fluorescent proteins Proteins 0.000 description 2
- VGIRNWJSIRVFRT-UHFFFAOYSA-N 2',7'-difluorofluorescein Chemical compound OC(=O)C1=CC=CC=C1C1=C2C=C(F)C(=O)C=C2OC2=CC(O)=C(F)C=C21 VGIRNWJSIRVFRT-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- 102100027324 2-hydroxyacyl-CoA lyase 1 Human genes 0.000 description 1
- 102100024385 28S ribosomal protein S35, mitochondrial Human genes 0.000 description 1
- 101150090724 3 gene Proteins 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- 102100023176 52 kDa repressor of the inhibitor of the protein kinase Human genes 0.000 description 1
- 102100041029 60S ribosomal protein L9 Human genes 0.000 description 1
- 102100027401 A disintegrin and metalloproteinase with thrombospondin motifs 3 Human genes 0.000 description 1
- 108091005661 ADAMTS3 Proteins 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 102100022900 Actin, cytoplasmic 1 Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- 102100034163 Alpha-actinin-1 Human genes 0.000 description 1
- 102100034290 Ankyrin repeat domain-containing protein 22 Human genes 0.000 description 1
- 241000501754 Astronotus ocellatus Species 0.000 description 1
- 208000031729 Bacteremia Diseases 0.000 description 1
- 108090000363 Bacterial Luciferases Proteins 0.000 description 1
- 201000001178 Bacterial Pneumonia Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 206010069748 Burkholderia pseudomallei infection Diseases 0.000 description 1
- 229930182476 C-glycoside Natural products 0.000 description 1
- 150000000700 C-glycosides Chemical class 0.000 description 1
- 102100040841 C-type lectin domain family 5 member A Human genes 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 108010022366 Carcinoembryonic Antigen Proteins 0.000 description 1
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 108010072135 Cell Adhesion Molecule-1 Proteins 0.000 description 1
- 102100024649 Cell adhesion molecule 1 Human genes 0.000 description 1
- 241000178548 Cerianthus Species 0.000 description 1
- 102000019034 Chemokines Human genes 0.000 description 1
- 108010012236 Chemokines Proteins 0.000 description 1
- 206010009192 Circulatory collapse Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 108020004394 Complementary RNA Proteins 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 206010011409 Cross infection Diseases 0.000 description 1
- 239000003155 DNA primer Substances 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 102100020743 Dipeptidase 1 Human genes 0.000 description 1
- 108090000204 Dipeptidase 1 Proteins 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 208000037487 Endotoxemia Diseases 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 108090000331 Firefly luciferases Proteins 0.000 description 1
- 102000003817 Fos-related antigen 1 Human genes 0.000 description 1
- 108090000123 Fos-related antigen 1 Proteins 0.000 description 1
- 102100040136 Free fatty acid receptor 3 Human genes 0.000 description 1
- 102100033864 G-protein coupled receptor 84 Human genes 0.000 description 1
- 102000013446 GTP Phosphohydrolases Human genes 0.000 description 1
- 108091006109 GTPases Proteins 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 102000053187 Glucuronidase Human genes 0.000 description 1
- 108010060309 Glucuronidase Proteins 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 102100026119 High affinity immunoglobulin gamma Fc receptor IB Human genes 0.000 description 1
- 102100030095 Histone-lysine N-methyltransferase SETD1B Human genes 0.000 description 1
- 101150068639 Hnf4a gene Proteins 0.000 description 1
- 101001009252 Homo sapiens 2-hydroxyacyl-CoA lyase 1 Proteins 0.000 description 1
- 101000727483 Homo sapiens 28S ribosomal protein S28, mitochondrial Proteins 0.000 description 1
- 101000689823 Homo sapiens 28S ribosomal protein S35, mitochondrial Proteins 0.000 description 1
- 101001113900 Homo sapiens 52 kDa repressor of the inhibitor of the protein kinase Proteins 0.000 description 1
- 101000672886 Homo sapiens 60S ribosomal protein L9 Proteins 0.000 description 1
- 101000799406 Homo sapiens Alpha-actinin-1 Proteins 0.000 description 1
- 101000780100 Homo sapiens Ankyrin repeat domain-containing protein 22 Proteins 0.000 description 1
- 101000749314 Homo sapiens C-type lectin domain family 5 member A Proteins 0.000 description 1
- 101000890662 Homo sapiens Free fatty acid receptor 3 Proteins 0.000 description 1
- 101001069589 Homo sapiens G-protein coupled receptor 84 Proteins 0.000 description 1
- 101000913077 Homo sapiens High affinity immunoglobulin gamma Fc receptor IB Proteins 0.000 description 1
- 101000864672 Homo sapiens Histone-lysine N-methyltransferase SETD1B Proteins 0.000 description 1
- 101000945438 Homo sapiens Kelch domain-containing protein 2 Proteins 0.000 description 1
- 101001004946 Homo sapiens Lactoylglutathione lyase Proteins 0.000 description 1
- 101000993450 Homo sapiens Metal transporter CNNM3 Proteins 0.000 description 1
- 101000578830 Homo sapiens Methionine aminopeptidase 1 Proteins 0.000 description 1
- 101000585693 Homo sapiens Mitochondrial 2-oxodicarboxylate carrier Proteins 0.000 description 1
- 101000690083 Homo sapiens Mitochondrial RNA pseudouridine synthase RPUSD4 Proteins 0.000 description 1
- 101000798951 Homo sapiens Mitochondrial import receptor subunit TOM20 homolog Proteins 0.000 description 1
- 101001008816 Homo sapiens N-lysine methyltransferase KMT5A Proteins 0.000 description 1
- 101000651201 Homo sapiens N-sulphoglucosamine sulphohydrolase Proteins 0.000 description 1
- 101001023833 Homo sapiens Neutrophil gelatinase-associated lipocalin Proteins 0.000 description 1
- 101000634707 Homo sapiens Nucleolar complex protein 3 homolog Proteins 0.000 description 1
- 101001129191 Homo sapiens Omega-hydroxyceramide transacylase Proteins 0.000 description 1
- 101001041245 Homo sapiens Ornithine decarboxylase Proteins 0.000 description 1
- 101000614405 Homo sapiens P2X purinoceptor 1 Proteins 0.000 description 1
- 101000915565 Homo sapiens Palmitoyltransferase ZDHHC3 Proteins 0.000 description 1
- 101000579913 Homo sapiens Peroxisomal trans-2-enoyl-CoA reductase Proteins 0.000 description 1
- 101001096022 Homo sapiens Phospholipase B1, membrane-associated Proteins 0.000 description 1
- 101001097889 Homo sapiens Platelet-activating factor acetylhydrolase Proteins 0.000 description 1
- 101000827703 Homo sapiens Polyphosphoinositide phosphatase Proteins 0.000 description 1
- 101000974726 Homo sapiens Potassium voltage-gated channel subfamily E member 1 Proteins 0.000 description 1
- 101000904181 Homo sapiens Probable gluconokinase Proteins 0.000 description 1
- 101000728245 Homo sapiens Protein Aster-C Proteins 0.000 description 1
- 101000942742 Homo sapiens Protein lin-7 homolog A Proteins 0.000 description 1
- 101000574322 Homo sapiens Protein phosphatase 1M Proteins 0.000 description 1
- 101001092182 Homo sapiens Ral-GDS-related protein Proteins 0.000 description 1
- 101000731730 Homo sapiens Rho guanine nucleotide exchange factor 18 Proteins 0.000 description 1
- 101000828738 Homo sapiens Selenide, water dikinase 2 Proteins 0.000 description 1
- 101000863883 Homo sapiens Sialic acid-binding Ig-like lectin 9 Proteins 0.000 description 1
- 101000587717 Homo sapiens Sulfide:quinone oxidoreductase, mitochondrial Proteins 0.000 description 1
- 101000891367 Homo sapiens Transcobalamin-1 Proteins 0.000 description 1
- 101000899433 Homo sapiens Transmembrane protein C1orf162 Proteins 0.000 description 1
- 101000740762 Homo sapiens Voltage-dependent calcium channel subunit alpha-2/delta-3 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 108090000890 Interferon regulatory factor 1 Proteins 0.000 description 1
- 102000004289 Interferon regulatory factor 1 Human genes 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108010063738 Interleukins Proteins 0.000 description 1
- 102000015696 Interleukins Human genes 0.000 description 1
- 206010059176 Juvenile idiopathic arthritis Diseases 0.000 description 1
- 108091007984 KARS Proteins 0.000 description 1
- 108010025815 Kanamycin Kinase Proteins 0.000 description 1
- 102100033609 Kelch domain-containing protein 2 Human genes 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- 102100026004 Lactoylglutathione lyase Human genes 0.000 description 1
- 241000254158 Lampyridae Species 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 108060001084 Luciferase Proteins 0.000 description 1
- 239000005089 Luciferase Substances 0.000 description 1
- 102100035529 Lysine-tRNA ligase Human genes 0.000 description 1
- 239000007987 MES buffer Substances 0.000 description 1
- 206010027280 Meningococcal sepsis Diseases 0.000 description 1
- 102100031678 Metal transporter CNNM3 Human genes 0.000 description 1
- 102100028379 Methionine aminopeptidase 1 Human genes 0.000 description 1
- 102100024048 Mitochondrial RNA pseudouridine synthase RPUSD4 Human genes 0.000 description 1
- 102100034007 Mitochondrial import receptor subunit TOM20 homolog Human genes 0.000 description 1
- 241000713869 Moloney murine leukemia virus Species 0.000 description 1
- 208000034486 Multi-organ failure Diseases 0.000 description 1
- 208000010718 Multiple Organ Failure Diseases 0.000 description 1
- 208000004221 Multiple Trauma Diseases 0.000 description 1
- 101000574441 Mus musculus Alkaline phosphatase, germ cell type Proteins 0.000 description 1
- 101100013973 Mus musculus Gata4 gene Proteins 0.000 description 1
- 101100518987 Mus musculus Pax1 gene Proteins 0.000 description 1
- 101100518992 Mus musculus Pax2 gene Proteins 0.000 description 1
- 101100351020 Mus musculus Pax5 gene Proteins 0.000 description 1
- 102100027771 N-lysine methyltransferase KMT5A Human genes 0.000 description 1
- 102100027661 N-sulphoglucosamine sulphohydrolase Human genes 0.000 description 1
- 101150007813 NIH gene Proteins 0.000 description 1
- 102100035405 Neutrophil gelatinase-associated lipocalin Human genes 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 1
- 102100029099 Nucleolar complex protein 3 homolog Human genes 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102100031247 Omega-hydroxyceramide transacylase Human genes 0.000 description 1
- 102100039506 Organic solute transporter subunit alpha Human genes 0.000 description 1
- 102100021079 Ornithine decarboxylase Human genes 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 108700005081 Overlapping Genes Proteins 0.000 description 1
- 102100040444 P2X purinoceptor 1 Human genes 0.000 description 1
- 238000009004 PCR Kit Methods 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102100028620 Palmitoyltransferase ZDHHC3 Human genes 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- 102100027506 Peroxisomal trans-2-enoyl-CoA reductase Human genes 0.000 description 1
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 1
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 1
- 102100037883 Phospholipase B1, membrane-associated Human genes 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 108010004729 Phycoerythrin Proteins 0.000 description 1
- 102100037518 Platelet-activating factor acetylhydrolase Human genes 0.000 description 1
- 102100023591 Polyphosphoinositide phosphatase Human genes 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 102100022755 Potassium voltage-gated channel subfamily E member 1 Human genes 0.000 description 1
- 241000288906 Primates Species 0.000 description 1
- 102100030090 Probable ATP-dependent RNA helicase DHX58 Human genes 0.000 description 1
- 102100024009 Probable gluconokinase Human genes 0.000 description 1
- 102100029804 Protein Aster-C Human genes 0.000 description 1
- 102100032928 Protein lin-7 homolog A Human genes 0.000 description 1
- 102100025776 Protein phosphatase 1M Human genes 0.000 description 1
- KDCGOANMDULRCW-UHFFFAOYSA-N Purine Natural products N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 1
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
- 108010066717 Q beta Replicase Proteins 0.000 description 1
- 108091005685 RIG-I-like receptors Proteins 0.000 description 1
- 102100035582 Ral-GDS-related protein Human genes 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 208000013616 Respiratory Distress Syndrome Diseases 0.000 description 1
- 208000004756 Respiratory Insufficiency Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- 102100032432 Rho guanine nucleotide exchange factor 18 Human genes 0.000 description 1
- 108091028664 Ribonucleotide Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 108091006629 SLC13A2 Proteins 0.000 description 1
- 108091006519 SLC26A8 Proteins 0.000 description 1
- 108091007630 SLC51A1 Proteins 0.000 description 1
- 101150058731 STAT5A gene Proteins 0.000 description 1
- 108010077895 Sarcosine Proteins 0.000 description 1
- 102100023522 Selenide, water dikinase 2 Human genes 0.000 description 1
- 108010047827 Sialic Acid Binding Immunoglobulin-like Lectins Proteins 0.000 description 1
- 102000007073 Sialic Acid Binding Immunoglobulin-like Lectins Human genes 0.000 description 1
- 102100029965 Sialic acid-binding Ig-like lectin 9 Human genes 0.000 description 1
- 102100030403 Signal peptide peptidase-like 2A Human genes 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 101150068300 Sppl2a gene Proteins 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- 102100031138 Sulfide:quinone oxidoreductase, mitochondrial Human genes 0.000 description 1
- 102100035265 Testis anion transporter 1 Human genes 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 206010044314 Tracheobronchitis Diseases 0.000 description 1
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 description 1
- 102100040396 Transcobalamin-1 Human genes 0.000 description 1
- 102000009618 Transforming Growth Factors Human genes 0.000 description 1
- 108010009583 Transforming Growth Factors Proteins 0.000 description 1
- 102100022518 Transmembrane protein C1orf162 Human genes 0.000 description 1
- 108091061763 Triple-stranded DNA Proteins 0.000 description 1
- 108010020713 Tth polymerase Proteins 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 102100037054 Voltage-dependent calcium channel subunit alpha-2/delta-3 Human genes 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 101100351021 Xenopus laevis pax5 gene Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000001594 aberrant effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 102000006646 aminoglycoside phosphotransferase Human genes 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 101150024767 arnT gene Proteins 0.000 description 1
- JPIYZTWMUGTEHX-UHFFFAOYSA-N auramine O free base Chemical compound C1=CC(N(C)C)=CC=C1C(=N)C1=CC=C(N(C)C)C=C1 JPIYZTWMUGTEHX-UHFFFAOYSA-N 0.000 description 1
- 238000003705 background correction Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- 102000005936 beta-Galactosidase Human genes 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 238000009640 blood culture Methods 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 208000037815 bloodstream infection Diseases 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 238000010804 cDNA synthesis Methods 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 230000022131 cell cycle Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000004640 cellular pathway Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000011436 cob Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 230000004154 complement system Effects 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 239000005547 deoxyribonucleotide Substances 0.000 description 1
- 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 239000000104 diagnostic biomarker Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000008482 dysregulation Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 239000002158 endotoxin Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 108010021843 fluorescent protein 583 Proteins 0.000 description 1
- 108091006047 fluorescent proteins Proteins 0.000 description 1
- 102000034287 fluorescent proteins Human genes 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 101150064107 fosB gene Proteins 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000003500 gene array Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- ZJYYHGLJYGJLLN-UHFFFAOYSA-N guanidinium thiocyanate Chemical compound SC#N.NC(N)=N ZJYYHGLJYGJLLN-UHFFFAOYSA-N 0.000 description 1
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical class O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000033444 hydroxylation Effects 0.000 description 1
- 238000005805 hydroxylation reaction Methods 0.000 description 1
- 238000005286 illumination Methods 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000008088 immune pathway Effects 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 238000000126 in silico method Methods 0.000 description 1
- 238000012606 in vitro cell culture Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 108091005434 innate immune receptors Proteins 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 230000010468 interferon response Effects 0.000 description 1
- 229940047122 interleukins Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000011901 isothermal amplification Methods 0.000 description 1
- 150000002540 isothiocyanates Chemical class 0.000 description 1
- 238000011005 laboratory method Methods 0.000 description 1
- 101150066555 lacZ gene Proteins 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 238000007834 ligase chain reaction Methods 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004880 lymph fluid Anatomy 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000010339 medical test Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 201000004015 melioidosis Diseases 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 239000002082 metal nanoparticle Substances 0.000 description 1
- 230000011987 methylation Effects 0.000 description 1
- 238000007069 methylation reaction Methods 0.000 description 1
- 239000011325 microbead Substances 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 238000000386 microscopy Methods 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 230000002438 mitochondrial effect Effects 0.000 description 1
- 230000003990 molecular pathway Effects 0.000 description 1
- 208000029744 multiple organ dysfunction syndrome Diseases 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000000066 myeloid cell Anatomy 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 238000002966 oligonucleotide array Methods 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 238000003068 pathway analysis Methods 0.000 description 1
- 238000003909 pattern recognition Methods 0.000 description 1
- 108010089193 pattern recognition receptors Proteins 0.000 description 1
- 102000007863 pattern recognition receptors Human genes 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 102000054765 polymorphisms of proteins Human genes 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 239000000092 prognostic biomarker Substances 0.000 description 1
- 230000001915 proofreading effect Effects 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- IGFXRKMLLMBKSA-UHFFFAOYSA-N purine Chemical compound N1=C[N]C2=NC=NC2=C1 IGFXRKMLLMBKSA-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 108010054624 red fluorescent protein Proteins 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 239000013643 reference control Substances 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 201000004193 respiratory failure Diseases 0.000 description 1
- 230000036387 respiratory rate Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 239000002336 ribonucleotide Substances 0.000 description 1
- 125000002652 ribonucleotide group Chemical group 0.000 description 1
- 150000008223 ribosides Chemical class 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 229940043230 sarcosine Drugs 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000010972 statistical evaluation Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000004416 surface enhanced Raman spectroscopy Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 208000020408 systemic-onset juvenile idiopathic arthritis Diseases 0.000 description 1
- 210000001138 tear Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- ZSLUVFAKFWKJRC-UHFFFAOYSA-N thorium Chemical compound [Th] ZSLUVFAKFWKJRC-UHFFFAOYSA-N 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 238000012085 transcriptional profiling Methods 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 230000003827 upregulation Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/20—Polymerase chain reaction [PCR]; Primer or probe design; Probe optimisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
- Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Theoretical Computer Science (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Evolutionary Biology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Analytical Chemistry (AREA)
- Public Health (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Data Mining & Analysis (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Databases & Information Systems (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Primary Health Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562132293P | 2015-03-12 | 2015-03-12 | |
| US62/132,293 | 2015-03-12 | ||
| PCT/US2016/022233 WO2016145426A1 (en) | 2015-03-12 | 2016-03-12 | Methods for diagnosis of sepsis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2977422A1 true CA2977422A1 (en) | 2016-09-15 |
Family
ID=56878909
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2977422A Pending CA2977422A1 (en) | 2015-03-12 | 2016-03-12 | Methods for diagnosis of sepsis |
Country Status (8)
| Country | Link |
|---|---|
| US (3) | US10533224B2 (enExample) |
| EP (1) | EP3268499B1 (enExample) |
| JP (3) | JP6995622B2 (enExample) |
| CN (1) | CN107532214B (enExample) |
| AU (2) | AU2016228508A1 (enExample) |
| CA (1) | CA2977422A1 (enExample) |
| IL (3) | IL297699A (enExample) |
| WO (1) | WO2016145426A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3519594B1 (en) * | 2016-09-29 | 2022-09-07 | Secretary of State for Health and Social Care | Assay for distinguishing between sepsis and systemic inflammatory response syndrome |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015135071A1 (en) | 2014-03-14 | 2015-09-17 | Hancock Robert E W | Diagnostic for sepsis |
| US20190354814A1 (en) * | 2017-01-08 | 2019-11-21 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Systems and methods for using supervised learning to predict subject-specific bacteremia outcomes |
| EP3477305A1 (en) | 2017-10-25 | 2019-05-01 | Universität Heidelberg | Delta-like ligand 1 for diagnosing severe infections |
| US10433191B2 (en) * | 2018-01-08 | 2019-10-01 | Cisco Technology, Inc. | Channel management in a virtual access point (VAP) |
| US11538566B2 (en) * | 2018-05-23 | 2022-12-27 | Beckman Coulter, Inc. | Sample analysis with test determination based on identified condition |
| US20210369797A1 (en) * | 2018-10-04 | 2021-12-02 | Western Sydney Local Health District | Bacteriophage treatment and reduction in inflammatory response |
| WO2020096984A1 (en) * | 2018-11-05 | 2020-05-14 | Institute For Systems Biology | Sepsis biomarker panels and methods of use |
| CN113785074A (zh) | 2019-03-25 | 2021-12-10 | 斯坦福大学托管董事会 | 用于诊断细菌感染与病毒感染的特征 |
| US11104946B2 (en) | 2019-04-23 | 2021-08-31 | Inflammatix, Inc. | DNA sequences related to diagnosis and treatment of systemic inflammatory response syndrome |
| CN112391460A (zh) * | 2019-08-19 | 2021-02-23 | 四川生美思达生物科技有限公司 | 用于脓毒症的生物标志物组及脓毒症判断方法和试剂盒 |
| CA3098079C (en) * | 2019-12-13 | 2023-06-20 | Autonomous Medical Devices Inc. | Apparatus and method for point-of-care, rapid, field-deployable diagnostic testing of covid-19, viruses, antibodies and markers |
| KR102281512B1 (ko) * | 2020-03-26 | 2021-07-23 | 경북대학교 산학협력단 | TGFBIp의 아세틸화 수준을 측정하는 제제를 포함하는 염증성 질환 진단용 조성물 |
| JP2023525489A (ja) * | 2020-04-29 | 2023-06-16 | インフラマティックス インコーポレイテッド | ウイルス感染症を有する対象の死亡率リスクの決定 |
| CN111563891B (zh) * | 2020-05-09 | 2023-09-26 | 吾征智能技术(北京)有限公司 | 基于颜色认知的疾病预测系统 |
| FR3112207A1 (fr) * | 2020-07-06 | 2022-01-07 | bioMérieux | Procédé pour déterminer le risque de survenue d’une infection associée aux soins chez un patient |
| FR3112209A1 (fr) * | 2020-07-06 | 2022-01-07 | bioMérieux | Procédé pour déterminer le risque de complication chez un patient |
| FR3112211A1 (fr) * | 2020-07-06 | 2022-01-07 | bioMérieux | Procédé pour déterminer le risque de survenue d’une infection associée aux soins chez un patient |
| CN111721941B (zh) * | 2020-07-17 | 2023-08-25 | 南方科技大学 | 一种用于判断脓毒症感染情况的装置及其应用 |
| WO2022066963A1 (en) * | 2020-09-25 | 2022-03-31 | The Board Of Trustees Of The Leland Stanford Junior University | Method for determining a virally-infected subject's risk of developing severe symptoms |
| JP2024520049A (ja) | 2021-05-25 | 2024-05-21 | ザ ユニヴァーシティ オブ ブリティッシュ コロンビア | 敗血症のエンドタイプおよび／または重症度の診断 |
| WO2023023125A1 (en) * | 2021-08-17 | 2023-02-23 | Predigen, Inc. | Methods for characterizing infections and methods for developing tests for the same |
| CN115295151B (zh) * | 2022-09-01 | 2024-12-27 | 中山大学附属第三医院 | 脓毒症预测系统、预测模型构建方法及系统、试剂盒 |
| CN120809235A (zh) * | 2025-09-04 | 2025-10-17 | 华中科技大学同济医学院附属同济医院 | 一种基于人工智能的多发伤患者脓毒症的早期预警方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004009952B4 (de) * | 2004-03-01 | 2011-06-01 | Sirs-Lab Gmbh | Verfahren zur Erkennung von Sepsis |
| SG119251A1 (en) * | 2004-08-04 | 2006-02-28 | Agency Science Tech & Res | Methods |
| BRPI0609302A2 (pt) * | 2005-04-15 | 2011-10-11 | Becton Dickinson Co | métodos para prever o desenvolvimento de sepse e para diagnosticar sepse em um indivìduo a ser testado, microarranjo, kit para prever o desenvolvimento de sepse em um indivìduo a ser testado, produto de programa de computador, computador, sistema de computador para determinar se um indivìduo é susceptìvel de desenvolver sepse, sinal digital embutido em uma onda portadora, e, interface gráfica de usuário para determinar se um indivìduo é susceptìvel de desenvolver sepse |
| DE102005050933A1 (de) * | 2005-10-21 | 2007-04-26 | Justus-Liebig-Universität Giessen | Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen |
| EP2643483A4 (en) * | 2010-11-26 | 2014-04-30 | Immunexpress Pty Ltd | DIAGNOSTIC AND / OR SCREENING APPROPRIATIONS AND USES THEREFOR |
| US20150038351A1 (en) | 2012-09-11 | 2015-02-05 | The Regents Of The University Of California | Gene Signatures That Predispose Or Protect Individuals From Low-Dose Radiation Induced Breast Cancer Or Are Associated with Disease-Free Survival |
| WO2014201516A2 (en) * | 2013-06-20 | 2014-12-24 | Immunexpress Pty Ltd | Biomarker identification |
-
2016
- 2016-03-12 EP EP16762690.2A patent/EP3268499B1/en active Active
- 2016-03-12 US US15/526,306 patent/US10533224B2/en active Active
- 2016-03-12 WO PCT/US2016/022233 patent/WO2016145426A1/en not_active Ceased
- 2016-03-12 AU AU2016228508A patent/AU2016228508A1/en not_active Abandoned
- 2016-03-12 JP JP2017546801A patent/JP6995622B2/ja active Active
- 2016-03-12 CN CN201680023601.1A patent/CN107532214B/zh active Active
- 2016-03-12 IL IL297699A patent/IL297699A/en unknown
- 2016-03-12 CA CA2977422A patent/CA2977422A1/en active Pending
-
2017
- 2017-08-30 IL IL254229A patent/IL254229B/en unknown
-
2019
- 2019-11-20 US US16/689,926 patent/US20200131577A1/en not_active Abandoned
-
2021
- 2021-09-30 IL IL286853A patent/IL286853B2/en unknown
- 2021-12-15 JP JP2021203291A patent/JP2022058359A/ja active Pending
-
2022
- 2022-05-18 AU AU2022203348A patent/AU2022203348A1/en not_active Abandoned
-
2023
- 2023-03-08 US US18/180,833 patent/US20230227911A1/en active Pending
- 2023-06-30 JP JP2023107866A patent/JP2023138990A/ja active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3519594B1 (en) * | 2016-09-29 | 2022-09-07 | Secretary of State for Health and Social Care | Assay for distinguishing between sepsis and systemic inflammatory response syndrome |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2023138990A (ja) | 2023-10-03 |
| CN107532214B (zh) | 2021-08-31 |
| IL286853A (en) | 2021-10-31 |
| JP6995622B2 (ja) | 2022-01-14 |
| EP3268499A1 (en) | 2018-01-17 |
| EP3268499A4 (en) | 2018-09-05 |
| JP2022058359A (ja) | 2022-04-12 |
| IL297699A (en) | 2022-12-01 |
| IL254229A0 (en) | 2017-10-31 |
| AU2022203348A1 (en) | 2022-06-09 |
| US20200131577A1 (en) | 2020-04-30 |
| US20180291449A1 (en) | 2018-10-11 |
| US20230227911A1 (en) | 2023-07-20 |
| IL286853B (en) | 2022-12-01 |
| AU2016228508A1 (en) | 2017-09-07 |
| WO2016145426A1 (en) | 2016-09-15 |
| IL254229B (en) | 2021-10-31 |
| US10533224B2 (en) | 2020-01-14 |
| EP3268499B1 (en) | 2020-05-13 |
| JP2018514189A (ja) | 2018-06-07 |
| WO2016145426A8 (en) | 2017-04-06 |
| CN107532214A (zh) | 2018-01-02 |
| IL286853B2 (en) | 2023-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20230227911A1 (en) | Methods for Diagnosis of Sepsis | |
| US20240410007A1 (en) | Gene expression profiles associated with sub-clinical kidney transplant rejection | |
| US12071668B2 (en) | Gene expression signatures useful to predict or diagnose sepsis and methods of using the same | |
| US10640829B2 (en) | Biomarkers for Inflammatory Bowel Disease | |
| CA3001134A1 (en) | Methods for diagnosis of tuberculosis | |
| CN106755415A (zh) | 用于诊断和预测移植物排斥的生物标志物板 | |
| EP3825416A2 (en) | Gene expression profiles associated with sub-clinical kidney transplant rejection | |
| CA2674211A1 (en) | Methods and kits for diagnosis and/or prognosis of the tolerant state in liver transplantation | |
| AU2021221905B2 (en) | Gene expression profiles associated with sub-clinical kidney transplant rejection | |
| US20220205042A1 (en) | Molecular Signatures for Distinguishing Liver Transplant Rejections or Injuries | |
| US20250218537A1 (en) | Methods for diagnosing myocardial infarction | |
| WO2020096796A1 (en) | Method for predicting severe dengue | |
| US11104951B2 (en) | Molecular signatures for distinguishing liver transplant rejections or injuries | |
| HK40007518B (en) | Biomarkers for inflammatory bowel disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20210309 |
|
| EEER | Examination request |
Effective date: 20210309 |
|
| EEER | Examination request |
Effective date: 20210309 |
|
| EEER | Examination request |
Effective date: 20210309 |
|
| EEER | Examination request |
Effective date: 20210309 |
|
| EEER | Examination request |
Effective date: 20210309 |